LANSING, MI, May 25, 2011 — Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announces today that Kim Thompson cordially invites all interested parties to participate in the Company’s conference call to be held on Friday, June 10, 2011 at 4:30 p.m. EDT.
Thompson, the Company’s CEO and Founder, will review the recent Sigma-Aldrich agreement and upcoming laboratory developments, as well as what is in the recombinant spider silk commercialization pipeline, followed by a question and answer period.
The conference call phone number and other details, including access codes, will be announced in a follow-up company release on the morning of the call. Shareholders are invited to submit questions to firstname.lastname@example.org and must be received by Thursday, June 9, to be considered.
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories is a fully reporting biotechnology company that recently achieved a series of scientific breakthroughs, with implications for the global textile industry. For further information please visit www.KraigLabs.com .
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “hopes,” “develops,” “researching,” “research,” “potential,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
Contact: Ben Hansel (720) 288-8495